All filters
Videos
Development of Immune Competent Small Animal Models for HBV | Helene Strick-Marchand
Presented at:
HEP DART 2017
Videos
Core Antibody: anti-HBc What is the Core of the Story? | Robert Gish, MD
Presented at:
HEP DART 2017
Videos
Endpoints and New Targets for Curing Hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Videos
Is Host Genome Integrated HBV Relevant? - The Con Perspective | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Videos
Short Duration DAA HCV Therapy: How Short Can We Go? | Shyam Kottilil, MD, PhD
Presented at:
HEP DART 2017
Videos
DAA Therapy and Reinfection Among People who Inject Drugs: Forming a Foundation for HCV Elimination | Jason Grebely
Presented at:
HEP DART 2017
Videos
Liver Disease in Chinese-perspective from a Hepatologist | George Lau, MBBS, MRCP, FHKCP, FHKAM, MD, FRCP
Presented at:
HEP DART 2017
Videos
Access to HIV, HBV, and HCV Antiviral Agents Globally | John Martin, PhD
Presented at:
HEP DART 2017
Videos
Global Strategies to Eliminate Hepatitis B (ICE-HBV) | Peter Revill
Presented at:
HEP DART 2017
Videos
Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition | Anna S. Lok, MD, DSc
Presented at:
HEP DART 2017
Videos
The French and European Approach Towards Hepatitis Elimination | Tarik Asselah, MD, PhD
Presented at:
HEP DART 2017
Videos
Strategy for the Elimination of Hepatitis B and C (Academy of Medicine Report) | Andrew Aronsohn, MD
Presented at:
HEP DART 2017
Videos
What challenges remain in viral hepatitis | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HCV elimination program in Georgia: Successes and challenges | Nikoloz Chkhartishvili, MD, MS, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Non liver and survival benefits of SVR in HCV | Marion Peters, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
The use of HIV+ or HCV+ organs in transplantation | Stefano Fagiuoli, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Pharmacologist's perspective | David Back, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017